|
CTNS expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.607040E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.052800E-01 |
| Normal-vs-Stage2 |
1.667780E-01 |
| Normal-vs-Stage3 |
1.568040E-01 |
| Normal-vs-Stage4 |
7.393600E-01 |
| Stage1-vs-Stage2 |
5.554200E-01 |
| Stage1-vs-Stage3 |
6.128200E-01 |
| Stage1-vs-Stage4 |
2.499600E-01 |
| Stage2-vs-Stage3 |
8.596800E-01 |
| Stage2-vs-Stage4 |
1.710750E-01 |
| Stage3-vs-Stage4 |
1.884800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.466960E-01 |
| Normal-vs-AfricanAmerican |
4.977600E-01 |
| Normal-vs-Asian |
1.529610E-01 |
| Caucasian-vs-AfricanAmerican |
7.698000E-01 |
| Caucasian-vs-Asian |
4.560800E-01 |
| AfricanAmerican-vs-Asian |
4.431800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.559800E-01 |
| Normal-vs-Female |
1.979960E-01 |
| Male-vs-Female |
8.325800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.149950E-01 |
| Normal-vs-Age(41-60Yrs) |
7.799400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.687210E-01 |
| Normal-vs-Age(81-100Yrs) |
2.227800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.570020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.110800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.391800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.205600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.531600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.850000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.903800E-01 |
| Classical-VS-Follicular |
5.646200E-01 |
| Classical-VS-Other |
6.940200E-02 |
| Classical-VS-Normal |
5.040200E-02 |
| Tall-VS-Follicular |
9.810200E-01 |
| Tall-VS-Other |
5.298300E-02 |
| Tall-VS-Normal |
4.368400E-01 |
| Follicular-VS-Other |
3.018800E-01 |
| Follicular-VS-Normal |
5.459200E-01 |
| Other-VS-Normal |
7.905700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.423600E-02 |
| Normal-vs-N1 |
1.882760E-01 |
| N0-vs-N1 |
8.880500E-03 |
|
|
